BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33162436)

  • 21. Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion.
    Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
    Sci Rep; 2019 Mar; 9(1):4721. PubMed ID: 30886226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer.
    Cannon NA; Meyer J; Iyengar P; Ahn C; Westover KD; Choy H; Timmerman R
    J Thorac Oncol; 2015 Feb; 10(2):280-5. PubMed ID: 25299234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma.
    Zhang T; Liu W; Xu C
    Front Oncol; 2023; 13():1166802. PubMed ID: 37746281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: A retrospective study.
    Wang Y; Hu X; Xu W; Wang H; Huang Y; Che G
    Thorac Cancer; 2019 Jun; 10(6):1402-1411. PubMed ID: 31104359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
    Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
    Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Shaverdian N; Veruttipong D; Wang J; Schaue D; Kupelian P; Lee P
    Clin Lung Cancer; 2016 Jan; 17(1):39-46. PubMed ID: 26372098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of preoperative blood markers as prognostic factors for lung cancer surgery.
    Hamid UI; Al-Saudi R; Paul I; Graham A
    Asian Cardiovasc Thorac Ann; 2019 May; 27(4):288-293. PubMed ID: 30832488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer].
    Yi F; Gu Y; Chen S; Liu Y; Yin W; Zhang Y; Cao B
    Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):481-492. PubMed ID: 29945708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.
    Jeong E; Hyun SH; Moon SH; Cho YS; Kim BT; Lee KH
    Medicine (Baltimore); 2017 Feb; 96(5):e5935. PubMed ID: 28151879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor.
    Chang WL; Yang WC; Zeng XY; Li CG; Xiong Z; Wang T; Zhang RZ; Tao KX; Zhang P
    BMC Gastroenterol; 2020 Apr; 20(1):124. PubMed ID: 32321434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative Elevations of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios Predict Postoperative Pulmonary Complications in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study.
    Wang Y; Hu X; Su MC; Wang YW; Che GW
    Curr Med Sci; 2020 Apr; 40(2):339-347. PubMed ID: 32337695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative Immune-Nutritional Abnormality Predicts Poor Outcome in Elderly Non-Small-Cell Lung Cancer Patients with Comorbidities.
    Miura N; Shoji F; Kozuma Y; Toyokawa G; Yamazaki K; Takeo S
    Ann Thorac Cardiovasc Surg; 2020 Oct; 26(5):240-247. PubMed ID: 31996508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-to-lymphocyte ratio predicts the prognosis of patients with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy.
    Toda M; Tsukioka T; Izumi N; Komatsu H; Okada S; Hara K; Miyamoto H; Ito R; Shibata T; Nishiyama N
    Thorac Cancer; 2018 Jan; 9(1):112-119. PubMed ID: 29105365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
    Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
    World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
    Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH
    Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative pulmonary function correlates with systemic inflammatory response and prognosis in patients with non-small cell lung cancer: results of a single-institution retrospective study.
    Gao Y; Zhang H; Li Y; Wang D; Ma Y; Chen Q
    Oncotarget; 2017 Apr; 8(16):27489-27501. PubMed ID: 28039482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer.
    Kos M; Hocazade C; Kos FT; Uncu D; Karakas E; Dogan M; Uncu HG; Yildirim N; Zengin N
    Wien Klin Wochenschr; 2016 Sep; 128(17-18):635-40. PubMed ID: 25720573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Meta-analysis of Platelet Lymphocyte Ratio as A Prognostic Factor for
Non-small Cell Lung Cancer].
    Chen H; Xue H; Liu W; Wu F; Wang Y; Gao H
    Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):289-298. PubMed ID: 31109438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.